G GSK

GSK Plc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company based in Brentford, UK, committed to improving health outcomes through its innovative portfolio which includes pharmaceuticals, vaccines, and consumer healthcare products. With a strong emphasis on research and development, GSK ...

$51.41

-5.62% ($3.06)

Volume 11.23M

52W High $61.70

52W Low $35.45

Market Cap $101.12B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Apr 29, 2026 Beat

Actual: $1.26 vs. Consensus: $1.16

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 4, 2026

1-Day: +3.39%

5-Day: +3.11%

Q3 2025 Oct 29, 2025

1-Day: +2.20%

5-Day: +0.91%

Q2 2025 Jul 30, 2025

1-Day: -4.67%

5-Day: -3.31%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$8.62B	+6.2%	69.7%	12.8%	$636.0M
Q3'25	$8.55B	+6.7%	73.6%	30.3%	$2.01B
Q2'25	$7.99B	+1.3%	72.9%	25.3%	$1.44B
Q1'25	$7.52B	+2.1%	74.2%	29.5%	$1.62B
Q4'24	$8.12B	+0.8%	68.5%	8.6%	$414.0M
Q3'24	$8.01B	-1.7%	70.1%	2.4%	-$58.0M
Q2'24	$7.88B	+9.8%	73.1%	20.9%	$1.17B
Q1'24	$7.36B	+5.9%	73.2%	20.2%	$1.05B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	Apr 29, 2026	$1.16	$1.26	$1.26	+8.62%	Met
Q4 2025	Feb 4, 2026	$0.64	$0.70	$0.70	+9.27%	Met
Q3 2025	Oct 29, 2025	$1.17	$1.26	$1.46	+24.46%	Beat
Q2 2025	Jul 30, 2025	$1.11	$1.20	$1.24	+11.71%	Beat
Q1 2025	Apr 30, 2025	$1.04	$1.14	$1.20	+15.38%	Beat
Q4 2024	Feb 5, 2025	$0.49	$0.52	$0.58	+18.37%	Beat
Q3 2024	Oct 30, 2024	$1.16	$1.24	$1.29	+11.21%	Beat
Q2 2024	Jul 31, 2024	$0.99	$1.06	$1.10	+11.11%	Beat
Q1 2024	May 1, 2024	$0.91	$0.95	$1.09	+19.78%	Beat
Q4 2023	Jan 31, 2024	$0.76	$0.82	$0.72	-5.26%	Missed
Q3 2023	Nov 1, 2023	$1.14	$1.22	$1.28	+12.28%	Beat
Q2 2023	Jul 26, 2023	$0.87	$0.95	$0.97	+11.49%	Beat